[福州-闽侯县]大有华夏生物医药集团有限公司

公司官网:ww***com[点击查看] 职能类别:生物工程/生物制药 职能类别:医药技术研发人员

工作职责：

? 负责纯化工艺的探索及优化，开发设计相应的纯化工艺流程，并组织实施工艺方法验证，确保质量稳定可靠；

? 具体负责对纯化、合成、氨解、质谱检测等设备仪器的日常维护保养；

? 及时准确地分析实验结果、汇报实验数据，并及时填写保存实验报告；

? GMP实验室的日常管理、清洁和环境维护；

? 其他上级经理交办的事宜

任职资格：

? 细胞生物学等相关专业本科及以上文化程度；

? 熟悉各种抗体表达体系，掌握抗体表达纯化流程和实验细节；

? 扎实的动手能力，能够独立进行实验，安排好实验的进程；

? 能够主动查阅中英文相关文献解决实验中遇到的问题；

? 细致、认真，具备责任心和良好的团队精神。

公司名称:大有华夏生物医药集团有限公司 公司类型:合资 公司规模:50-150人 公司介绍:大有华夏介绍 大有华夏生物医药集团成立于2016年9月，是杰出免疫学家、肿瘤学家陈列平教授在中国创建的致力于研发抗肿瘤免疫治疗创新药物的企业。 陈列平是全球肿瘤免疫治疗的先驱者，现任美国耶鲁大学UTC癌症研究讲席教授，美国耶鲁癌症中心免疫学部主任。陈列平教授关于阻断PD-1/PD-L1通路等癌症治疗方法与药物的研究，对癌症治疗具有革命性的意义， PD-1、PD-L1抗体药物已成为目前公认的最安全有效的抗肿瘤药物。 大有华夏的团队具有丰富的药物研发经验，正在研发的抗肿瘤创新药物包括免疫检查点抑制剂类、共刺激类、双特异性抗体类和创新生物标志物检测试剂类。未来，大有华夏集团将努力成长为涵盖研究、转化、生产等环节的全产业链生物医药企业。 TAYU-BIOTECH Introduction: TAYU Biotech group was established in September 2016, which is committed to develop innovative immunotherapy drug in China founded by Professor Chen Lieping who is a global famous immunologists and oncologists. Professor Chen Lieping is the world’s leading investigator in the characterization of cell surface co-stimulatory and co-inhibitory molecules that modulate immune responses. He is professor of immunobiology, of dermatology, and of medicine (medical oncology) at Yale School of Medicine and director of the cancer immunology program at the Yale Cancer Center. Professor Chen is the first scientist to apply co-stimulation as a mean for cancer immunotherapy. His laboratory discovered immune suppressive function of the B7-H1 (PD-L1)/PD-1 pathway in cancer and first demonstrated using antibody to block this pathway to enhance tumor immunity for the therapy of cancer. The anti-PD-1 and anti-PD-L1 has been well recognized as the most safe and effective drugs for the therapy of cancer so far. With a rich experienced R&D team, TAYU is developing anti-tumor drug including immune checkpoint inhibitors, co-stimulus antibodies, dual specificity antibodies and biomarker etc. TAYU group will strive to grow into a top biopharmaceuticals group that covers research, transformation and manufacture in the future. For more information please click ww***com[点击查看] Contact information: Address: 8-2 Dongdan Santiao, Dongcheng district, Beijing, China Tel: +86 10 67177097 E-mail：clara@